Oncoclinicas do Brasil - Asset Resilience Ratio
Oncoclinicas do Brasil (ONCO3) has an Asset Resilience Ratio of 5.34% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore Oncoclinicas do Brasil asset portfolio for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2024)
This chart shows how Oncoclinicas do Brasil's Asset Resilience Ratio has changed over time. See how leveraged is Oncoclinicas do Brasil's balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Oncoclinicas do Brasil's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Oncoclinicas do Brasil worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$162.75 Million | 1.98% |
| Short-term Investments | R$276.55 Million | 3.36% |
| Total Liquid Assets | R$439.31 Million | 5.34% |
Asset Resilience Insights
- Limited Liquidity: Oncoclinicas do Brasil maintains only 5.34% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Oncoclinicas do Brasil Industry Peers by Asset Resilience Ratio
Compare Oncoclinicas do Brasil's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ramsay Health Care Ltd
AU:RHC |
Medical Care Facilities | 3.49% |
|
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA |
Medical Care Facilities | 9.01% |
|
Pihlajalinna Oy
HE:PIHLIS |
Medical Care Facilities | 5.13% |
|
Max India Limited
NSE:MAXIND |
Medical Care Facilities | 17.16% |
|
Regis Healthcare Ltd
AU:REG |
Medical Care Facilities | 2.29% |
|
Oceania Healthcare Ltd
AU:OCA |
Medical Care Facilities | 0.01% |
|
Pacific Smiles Group Ltd
AU:PSQ |
Medical Care Facilities | 10.35% |
|
Freedom Care Group Holdings Ltd
AU:FCG |
Medical Care Facilities | 0.39% |
Annual Asset Resilience Ratio for Oncoclinicas do Brasil (2013–2024)
The table below shows the annual Asset Resilience Ratio data for Oncoclinicas do Brasil.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 16.16% | R$1.81 Billion ≈ $355.20 Million |
R$11.20 Billion ≈ $2.20 Billion |
+8.51pp |
| 2023-12-31 | 7.65% | R$702.41 Million ≈ $137.83 Million |
R$9.18 Billion ≈ $1.80 Billion |
-5.09pp |
| 2022-12-31 | 12.74% | R$1.05 Billion ≈ $205.47 Million |
R$8.22 Billion ≈ $1.61 Billion |
-19.85pp |
| 2021-12-31 | 32.59% | R$1.97 Billion ≈ $385.80 Million |
R$6.03 Billion ≈ $1.18 Billion |
+9.89pp |
| 2020-12-31 | 22.70% | R$770.34 Million ≈ $151.16 Million |
R$3.39 Billion ≈ $665.86 Million |
+3.84pp |
| 2019-12-31 | 18.86% | R$397.97 Million ≈ $78.09 Million |
R$2.11 Billion ≈ $414.07 Million |
+7.54pp |
| 2018-12-31 | 11.32% | R$152.65 Million ≈ $29.95 Million |
R$1.35 Billion ≈ $264.56 Million |
+11.28pp |
| 2015-12-31 | 0.04% | R$224.00K ≈ $43.95K |
R$522.46 Million ≈ $102.52 Million |
-1.32pp |
| 2014-12-31 | 1.36% | R$4.91 Million ≈ $962.84K |
R$360.93 Million ≈ $70.82 Million |
+0.41pp |
| 2013-12-31 | 0.95% | R$3.05 Million ≈ $599.25K |
R$320.43 Million ≈ $62.87 Million |
-- |
About Oncoclinicas do Brasil
Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, ch… Read more